ClinConnect ClinConnect Logo
Search / Trial NCT02913456

A European Registry Study to Prospectively Observe Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced (LA) or Metastatic Breast Cancer (mBC) (SAMANTHA)

Launched by HOFFMANN-LA ROCHE · Sep 22, 2016

Trial Information

Current as of July 23, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - Initially diagnosed with HER2-positive unresectable LA/mBC no more than 6 months prior to enrollment, although they can have received anti-cancer treatment during that time
  • Exclusion Criteria:
  • - Not applicable

About Hoffmann La Roche

Hoffmann-La Roche, commonly known as Roche, is a global leader in biotechnology and pharmaceuticals, committed to advancing healthcare through innovative research and development. With a strong focus on oncology, immunology, infectious diseases, and central nervous system disorders, Roche leverages cutting-edge science to deliver transformative therapies and diagnostics. The company is dedicated to improving patient outcomes by conducting rigorous clinical trials and collaborating with healthcare professionals and organizations worldwide. Roche's unwavering commitment to precision medicine and personalized healthcare positions it at the forefront of the industry, driving progress in the quest for effective treatments and improved patient care.

Locations

Ancona, Marche, Italy

Lisboa, , Portugal

Porto, , Portugal

Timisoara, , Romania

Bari, Puglia, Italy

Wien, , Austria

Brescia, Lombardia, Italy

Sant'andrea Delle Fratte (Pg), Umbria, Italy

Aviano (Pn), Friuli Venezia Giulia, Italy

Modena, Emilia Romagna, Italy

Coimbra, , Portugal

Cluj Napoca, , Romania

Graz, , Austria

Graz, , Austria

Wien, , Austria

Latina, Lazio, Italy

Ponderano (Bi), Piemonte, Italy

Alba Iulia, , Romania

Lisboa, , Portugal

Viterbo, Lazio, Italy

Bucuresti, , Romania

Sora, Lazio, Italy

Sofia, , Bulgaria

Camposampiero, Veneto, Italy

Loures, , Portugal

Plovdiv, , Bulgaria

Varna, , Bulgaria

Lucca, Toscana, Italy

Verona, Veneto, Italy

Palermo, Sicilia, Italy

Cona (Fe), Veneto, Italy

Sofia, , Bulgaria

Firenze, Toscana, Italy

Almada, , Portugal

Plovdiv, , Bulgaria

Craiova, , Romania

Ried Innkreis, , Austria

Klagenfurt, , Austria

Leoben, , Austria

Linz, , Austria

Villach, , Austria

Wiener Neustadt, , Austria

Wien, , Austria

Ruse, , Bulgaria

Sofia, , Bulgaria

Sofia, , Bulgaria

Sofia, , Bulgaria

Stara Zagora, , Bulgaria

Vratza, , Bulgaria

Barletta, Puglia, Italy

Catania, Sicilia, Italy

Legnago (Vr), Veneto, Italy

Bucharest, , Romania

Cluj Napoca, , Romania

Modena, Emilia Romagna, Italy

Patients applied

0 patients applied

Trial Officials

Clinical Trials

Study Director

Hoffmann-La Roche

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials